Trials / Unknown
UnknownNCT02061150
Neonatal Sepsis Workup for High Risk Newborns - Evaluation of Need and Ways to Prevent
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 48 Hours
- Healthy volunteers
- Not accepted
Summary
Sepsis is a significant cause of morbidity and mortality among newborns. Due to strict criteria and in order to diagnose and prevent early-onset group B streptococcal (EOGBS) sepsis, many infants undergo a sepsis workup due to risk factors alone, even though they are asymptomatic. Our goal is to evaluate the number of newborns that undergo sepsis workup due to risk factors alone, to determine the number of newborns having positive blood cultures, and to establish ways to reduce the number of asymptomatic infants undergoing sepsis workup.
Conditions
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2015-02-01
- Completion
- 2015-06-01
- First posted
- 2014-02-12
- Last updated
- 2014-02-12
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02061150. Inclusion in this directory is not an endorsement.